Zhitong Finance App News, Ruibo Bio-B (06938.HK) announced that the board of directors was recently informed by Dr. Gan Liming, the company's executive director, co-CEO and president of global R&D, that Dr. Gan Liming further purchased 6,800 H shares of the company in the open market with his own capital. Following the increase in holdings, as of July 10, 2026, Dr. Gan Liming has purchased a total of 20,000 H shares in the open market with his own capital.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.